TGF-β3 inhibits pentagastrin-stimulated gastric acid secretion in rats

Medical Science Monitor

Volumn 11, Issue 3, 2005, Pages

  Beckert, Stefan ^a   Wolf, Sebastian C ^a   Farrahi, Farshid ^b   Zittel, Tilman T ^a   Coerper, Stephan ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gastric acid secretion; Gastric ulcer; Gastric ulcer healing; Pentagastrin; TGF 3

Indexed keywords

PENTAGASTRIN; TRANSFORMING GROWTH FACTOR BETA3; RECOMBINANT PROTEIN; TGFB3 PROTEIN, RAT; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; GASTRODUODENAL ULCER; JUGULAR VEIN; MALE; NONHUMAN; RAT; STOMACH ACID SECRETION; STOMACH PH; STOMACH ULCER; ULCER HEALING; ANIMAL; DIGESTIVE TRACT INTUBATION; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PATHOPHYSIOLOGY; SECRETION; SPRAGUE DAWLEY RAT; STOMACH ACID; STOMACH FISTULA; TIME; WOUND HEALING;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GASTRIC ACID; GASTRIC FISTULA; HUMANS; INJECTIONS, INTRAVENOUS; INTUBATION, GASTROINTESTINAL; MALE; PENTAGASTRIN; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; STOMACH ULCER; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA3; WOUND HEALING;

EID: 15944409926     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Konturek PC, Konturek SJ, Czesnikiewicz M et al: Interaction of Helicobacter pylori (Hp) and nonsteroidal anti-inflammatory drugs (NSAID) on gastric mucosa and risk of ulcerations. Med Sci Monit, 2002;8(9):RA197-209
2. Tarnawski A, Santos AM, Ichikawa Y et al: Development, evolution and healing of experimental gastric ulcers: an overview. Eur J Gastroenterol Hepatol, 1993; 5: S5-S11
3. Bobrzynski A, Beben P, Budzynski A et al: Incidence of complications of peptic ulcers in patients with Helicobacter pylori (Hp) infection and/or NSAID use in the era of Hp eradication. Med Sci Monit, 2002; 8(8): CR554-557
4. Coerper S, Sigloch E, Cox D et al: Recombinant human transforming growth factor beta 3 accelerates gastric ulcer healing in rats. Scand J Gastroenterol, 1997; 32: 985-90
5. Coerper S, Wolf S, von Kiparski S et al: Insulin-like growth factor I accelerates gastric ulcer healing by stimulating cell proliferation and by inhibiting gastric acid secretion. Scand J Gastroenterol, 2001; 36(9): 921-276.
6. Kato S, Tanaka A, Ogawa Y et al: Effect of polaprezinc on impaired healing of chronic gastric ulcers in adjuvant-induced arthritic rats-role of insulin-like growth factors (IGF)-1. Med Sci Monit, 2001; 7(1): 20-25
7. Roberts AB, Sporn MB: The transforming growth factor-betas. In: Sporn MB, Roberts AB, editors. Handbook of experimental pharmacology: peptide growth factors and their receptors. New York: Springer-Verlag. 1990: 419-72
8. Cox DA: Transforming growth factor-beta 3. Cell Biol Int, 1995; 19: 357-71
9. Szabo S, Kusstatscher S, Sandor Z, Sakoulas G: Molecular and cellular basis of ulcer healing. Scand J Gastroenterol, 1995; 208: 3-8
10. Parekh T, Saxena B, Reibraan J et al: Neutrophil chemotaxis in response to TGF-β isoforms (TGF-β1, TGF-β2, TGF-β3) is mediated by fibronectin. J Immunol, 1994; 152: 2456-66
11. Cox DA, McMaster GK, Bùrgi R et al: Experimental wound healing studies with TGF-β3. Wound Repair Regen, 1994; 2: S208
12. Mustoe TA, Pierce GF, Thomason A et al: Accelerated healing of incisional wounds in rats induced by transforming growth factor-β. Science, 1987; 237: 1333-36
13. Brown GL, Curtsinger LJ, White M et al: Acceleration of tensile strength of incisions treated with EGF and TGF-beta. Ann Surg, 1988; 208: 788-94
14. Beck LS, DeGuzman L, Lee WP et al: One systemic administration of transforming growth factor-β1 reverses age- or glucocorticoid-impaired wound healing. J Clin Invest, 1993; 92: 2841-49
15. Konturek SJ, Brzozowski T, Majka J et al: Transforming growth factor alpha and epidermal growth factor in protection and healing of gastric mucosal injure Scand J Gastroenterol, 1992; 27: 649-55
16. Konturek PC, Brzozowski T, Konturek SJ et al: Expression of epidermal growth factor and transforming growth factor alpha during ulcer healing. Scand J Gastroenterol, 1997; 32: 6-15
17. Mustoe TA, Landes A, Cromack DT et al: Differential acceleration of healing of surgical incisions in the rabbit gastrointestinal tract by platelet-derived growth factor and transforming growth factor, type beta. Surgery, 1990; 108: 324-30
18. Konturek SJ, Cieszkowski M, Jaworek J et al: Effects of epidermal growth factor on gastrointestinal secretions. Am J Physiol, 1984; 246: G580-86
19. Konturek SJ, Dembinski A, Warzecha Z et al: Role of epidermal growth factor in healing of chronic gastroduodenal ulcers in rats. Gastroenterology, 1988; 94: 1300-7
20. Konturek SJ, Bielanski W, Konturek JW et al: Release and action of epidermal growth factor on gastric secretion in humans. Scand J Gastroenterol, 1989; 24: 485-92
21. Dembinski A, Gregory H, Konturek SJ, Polanski M: Trophic action of epidermal growth factor on the pancreas and gastroduodenal mucosa in rats. Am J Physiol, 1982; 325: 35-42
22. Konturek SJ, Radecki T, Brzozowski T et al: Gastric cytoprotection by epidermal growth factor. Gastroenterology, 1981; 81: 438-43
23. Ernst H, Konturek PC, Brzozowski T et al: Subserosal application of transforming growth factor-beta 1 in rats with chronic gastric ulcers: effect on gastric ulcer healing and blood flow. J Physiol Pharmacol, 1996; 47: 443-54
24. O'Kane S, Ferguson MW: Transforming growth factor beta s and wound healing. Int J Biochem Cell Biol, 1997; 29: 63-78
25. Perez-Aisa A, Sopena F, Arceiz E et al: Effect of exogenous administration of transforming growth factor-beta and famotidine on the healing of duodenal ulcer under the impact of indomethacin. Dig Liver Dis, 2003; 35 (6): 397-403
26. Wakefield LM, Winokur TS, Hollands RS et al: Recombinant latent transforming growth factor β1 has a longer plasma half-life in rats than active transforming growth factor β1, and a different tissue distribution. J Clin Invest, 1990; 86: 1976-84
27. Zioncheck TF, Chen SA, Richardson L et al: Pharmacokinetics and tissue distribution of recombinant human transforming growth factor beta 1 after topical and intravenous administration in male rats. Pharm Res, 1994; 11: 213-20
28. Massagué J, Hata A, Liu F: TGF signalling through the smad pathway. Trends Cell Biol, 1997; 7: 187-92
29. Lopez-Casillas F, Cheifetz S, Doody J et al: Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF β receptor system. Cell, 1991; 67: 785-95
30. Dockray GJ: Gastrin and gastric epithelial physiology. Journal of Physiology, 1999; 518(2): 315-24